SCHEMBL7185923

SCHEMBL7185923

COC(=O)CCC(Sc1ccccc1)B(O)OC(C)(C)C(C)(C)O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
CA12 O43570 2/20 0.33
CA7 P43166 2/20 0.33
CA9 Q16790 2/20 0.33
CA14 Q9ULX7 2/20 0.33
LMNA P02545 3/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PKM P14618 1/20 0.32
AKT1 P31749 1/20 0.32
SLC1A1 P43005 1/20 0.32
MAPT P10636 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
TSHR P16473 1/20 0.31
ESRRB O95718 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5838067 0.81 AAK1 (0.33)
SCHEMBL7191073 0.80 SMN1; SMN2 (0.32) SMN1; SMN2L3MBTL1POLBMAPK1CA9
SCHEMBL5837659 0.77
SCHEMBL7179298 0.73 L3MBTL1 (0.33) SMN1; SMN2L3MBTL1POLBMAPK1LMNA
SCHEMBL7187916 0.72 SLC1A1 (0.36) L3MBTL1SLC1A1TSHR
SCHEMBL24483651 0.65 LMNA (0.46) CA12CA7CA9CA14LMNA
SCHEMBL7648549 0.64 CTRB1 (0.38) KDM4EALDH1A1
SCHEMBL16063694 0.64 F2 (0.38) SMN1; SMN2POLBCA12CA7CA9
SCHEMBL5838358 0.63 ALDH1A1 (0.35) SMN1; SMN2L3MBTL1MAPK1LMNAALDH1A1
SCHEMBL28970084 0.63 MTNR1A (0.53) POLBCA12CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586615-B1 Boron compounds such as 1-amino-3,3-difluoropropyl boronate pinacol ester used as intermediates for antagonists of serine proteases, leukocyte elastases, cathepsins, chymotrypsin and hepatitis virus enzyme inhibitors BRISTOL-MYERS SQUIBB COMPANY 2003-07-01 US disclosed
WO-2002054931-A2 ALPHA-AMINOBORONIC ACIDS PREPARED BY NOVEL SYNTHETIC METHODS BRISTOL MYERS SQUIBB COMPANY P (US) 2002-07-18 WO disclosed
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed